TBA-7371

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTBA-7371
Drug Alias NameTBA-7371
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitors
TargetsFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase
Therapy Area/IndicationsTuberculosis, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Africa
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Pharmaceutical Co LtdBill & Melinda Gates Medical Research Institute
Inactive CompaniesN/A
Active IndicationsTuberculosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A